AC
TCBP

Armistice Capital’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Armistice Capital’s Portfolio TCBP Stock Details TCBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-463
Closed -$235K – 433
2023
Q4 		$235K Buy
463
+370
+398% +$417K ﹤0.01% 228
2023
Q3 		$128K Sell
93
-72
-44% -$119K ﹤0.01% 214
2023
Q2 		$286K Buy
165
+127
+334% +$408K ﹤0.01% 173
2023
Q1 		$193K Buy
38
+12
+46% +$167K ﹤0.01% 188
2022
Q4 		$318K Buy
+26
New +$639K 0.01% 149

Other funds holding TCBP

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HT
Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Armistice Capital's TCBP Position: Q1 2024 in Review

Armistice Capital sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q1 2024, closing a stake of 463 shares — an estimated $235K sold.

Armistice Capital first reported a position in TCBP in Q4 2022 and held it in 5 quarters. The position peaked at $318K in Q4 2022. 4 funds tracked by Wall St. Rank hold TCBP as of Q1 2024.

  • Armistice Capital reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Armistice Capital sold 463 TC BioPharm (Holdings) plc American Depositary Shares shares in Q1 2024, an estimated $235K.
  • Armistice Capital first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q4 2022 and held it in 5 quarters.
  • Armistice Capital's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $318K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q1 2024.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.